MoneyWorks4Me

Pfizer - Quaterly Results

17 May 2024 Evaluate
Revenue showed a marginal decline at Rs. 5466.30 millions. For the quarter ended March 2024, as compared to corresponding quarter of last year.The company has announced a 37.96% increase in its profits to Rs . 1788.60  millions for the  quarter ended March 2024 compared to Rs. 1296.50 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended March 2024 rose to 2645.60 millions as compared to 2132.50 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5466.30 5726.40 -4.54 21931.70 24247.60 -9.55 21931.70 24247.60 -9.55
Other Income 751.30 313.80 139.42 1805.10 1010.50 78.63 1805.10 1010.50 78.63
PBIDT 2645.60 2132.50 24.06 8158.10 9099.10 -10.34 8158.10 9099.10 -10.34
Interest 69.50 25.30 174.70 154.10 133.90 15.09 154.10 133.90 15.09
PBDT 2576.10 1911.30 34.78 8083.50 9295.20 -13.04 8083.50 9295.20 -13.04
Depreciation 137.50 264.10 -47.94 622.80 1055.10 -40.97 622.80 1055.10 -40.97
PBT 2438.60 1647.20 48.05 7460.70 8240.10 -9.46 7460.70 8240.10 -9.46
TAX 650.00 350.70 85.34 1947.40 2000.80 -2.67 1947.40 2000.80 -2.67
Deferred Tax 163.10 -315.30 -151.73 361.10 -519.10 -169.56 361.10 -519.10 -169.56
PAT 1788.60 1296.50 37.96 5513.30 6239.30 -11.64 5513.30 6239.30 -11.64
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 48.40 37.24 29.96 37.20 37.53 -0.87 37.20 37.53 -0.87
Peers
Company Name CMP
Sun Pharma. Inds. 1848.95
Dr. Reddys Labs. 1210.10
Cipla 1383.85
Lupin 2117.60
Zydus Lifesciences 1170.50
View more..